UTHSCSA Faculty Profiles v1.0
Rosende, Carlos A
School of Medicine
Ophthalmology
(210) 450-0636
rosende@uthscsa.edu
|
|
| 11/2010 - Present |
President and Chief Executive Officer |
UT Medicine San Antonio, San Antonio, TX |
| 11/2010 - Present |
Vice Dean of Clinical Affairs |
University of Texas Health Science Center at San Antonio, San Antonio, TX |
| 8/2010 - Present |
Professor |
University of Texas Health Science Center at San Antonio, Ophthalmology, San Antonio, TX |
| 1/2007 - Present |
Herbert F. Mueller Chair |
University of Texas Health Science Center at San Antonio, Ophthalmology, San Antonio, TX |
| Year |
Degree |
Discipline |
Institution |
| 1986 |
Residency |
Ophthalmology |
National Naval Medical Center
Bethesda , MD |
| 1982 |
Internship |
Internal Medicine |
Naval Medical Center
Portsmouth , VA |
| 1981 |
MD |
Medicine |
University of Miami School of Medicine
Miami , FL |
| 1977 |
BS |
Bioscience (B.S. with Distinction) |
United States Naval Academy
Annapolis , MD |
Diabetic Retinopathy |
Ophthalmology |
| Date |
Description |
Institution |
# Students |
| 8/1999 - Present |
Post-Doctoral Student Supervision |
University of Texas Health Science Center at San Antonio |
|
|
| 8/1999 - Present |
University Hospital Operating Room |
University Hospital, San Antonio, TX |
12 students |
|
| 8/1999 - Present |
Journal Clubs (Ophthalmology Dept.) |
University of Texas Health Science Center at San Antonio |
12 students |
| Discussant; held approximately once a month. |
| 8/1999 - Present |
Grand Rounds (Ophthalmology Dept.) |
University of Texas Health Science Center at San Antonio |
12 students |
|
Journal Article |
| Zhang Y, Peng Q, Kiel JW, Rosende CA, Duong TQ. Magnetic resonance imaging of vascular oxygenation changes during hyperoxia and carbogen challenges in the human retina Invest Ophthalmol Vis Sci 2011 Jan;52(1):286-291.
|
Abstract |
| Harris M, Rosende CA, Pollock BH, Ballentine CS. Incidence of Follow-up Examinations Within a Remote Diabetic Screening Program, (E-Abstract # 2506); 2009 Jan. (Invest Ophthalmol Vis Sci; vol. 50).
|
Private |
| Funding Agency |
Eli Lilly & Company |
| Title |
The Effect of Ruboxistaurin on Clinically Significant Macular Edema in Patients with Diabetes Mellitus, as assessed by Optical Coherence Tomography |
| Status |
Complete |
| Period |
1/2009 - 6/2011 |
| Role |
Principal Investigator |
| Grant Detail |
To evaluate the impact of ruboxistaurin mesylate on diabetic macular edema (DME) in patients with clinically significant macular edema and determine its effectiveness in maintaining or slowing the decrease of vision function in patients with DME. |
